MARISA STRINGER: Open Payments
NPI 1043327034 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,752 in 127 payments from 17 companies in 2025. Trend: 2023 $14,920 · 2024 $10,437 · 2025 $12,752
Speaker / faculty: $7,873Food & beverage: $2,550Travel & lodging: $2,228Education: $101
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 24 | $7,332 |
| Regeneron Healthcare Solutions, Inc. | 22 | $3,844 |
| ABBVIE INC. | 20 | $304 |
| Novartis Pharmaceuticals Corporation | 9 | $270 |
| LEO Pharma Inc. | 6 | $227 |
| Galderma Laboratories, L.P. | 23 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $113 |
| PFIZER INC. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Organon LLC | 3 | $64 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, Rhapsido, ANZUPGO, COSENTYX, ADBRY, RINVOQ.
Industry payments across MS — which companies pay providers there.
